Teladoc Health, Inc. (TDOC)
USD 9.46
(-6.06%)
USD 9.46
(-6.06%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.6 Billion | 2.4 Billion | 2.03 Billion | 1.09 Billion | 553.3 Million | 417.9 Million |
| Cost of Revenue | 760.03 Million | 743.98 Million | 650.25 Million | 390.82 Million | 184.46 Million | 128.73 Million |
| Gross Profit | 1.84 Billion | 1.66 Billion | 1.38 Billion | 703.13 Million | 368.84 Million | 289.17 Million |
| Operating Expenses | 2.09 Billion | 1.89 Billion | 1.62 Billion | 1.12 Billion | 442.66 Million | 355.13 Million |
| Selling, General and Administrative Expenses | 1.36 Billion | 1.3 Billion | 1.1 Billion | 886.88 Million | 339.06 Million | 263.04 Million |
| Research and Development Expenses | 348.52 Million | 333.62 Million | 311.88 Million | 164.94 Million | 64.64 Million | 54.37 Million |
| Other Expenses | 375.12 Million | 256.02 Million | 204.23 Million | 69.49 Million | 38.95 Million | 37.71 Million |
| Cost and Expenses | 2.85 Billion | 2.63 Billion | 2.27 Billion | 1.51 Billion | 627.12 Million | 483.87 Million |
| Operating Income | -248.55 Million | 13.19 Billion | -238.98 Million | -418.18 Million | -73.82 Million | -70.85 Million |
| Interest Expense | 22.28 Million | 9.27 Million | 80.36 Million | 60.49 Million | 29.01 Million | 26.11 Million |
| Income Tax Expense | 760 Thousand | -3.81 Million | 44.13 Million | -90.85 Million | -10.59 Million | 118 Thousand |
| Earnings before Tax | -219.6 Million | -13.66 Billion | -384.65 Million | -575.99 Million | -109.45 Million | -96.96 Million |
| Net Income | -220.36 Million | -13.65 Billion | -428.79 Million | -485.13 Million | -98.86 Million | -97.08 Million |
| Earnings Per Share Basic | -1.36 | -84.60 | -2.73 | -5.36 | -1.38 | -1.47 |
| Earnings Per Share Diluted | -1.34 | -84.60 | -2.73 | -5.36 | -1.38 | -1.47 |
| Weighted Average Shares Outstanding | 162.16 Million | 161.45 Million | 156.93 Million | 90.5 Million | 71.84 Million | 65.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 164.57 Million | 161.45 Million | 156.93 Million | 90.5 Million | 71.84 Million | 65.84 Million |
| Gross Margin | 0.71 | 0.69 | 0.68 | 0.64 | 0.67 | 0.69 |
| EBIT Margin | 0.06 | 5.60 | -0.01 | -0.31 | -0.05 | -0.07 |
| Profit Margin | -0.08 | -5.68 | -0.21 | -0.44 | -0.18 | -0.23 |
| EBITDA | 153.99 Million | -13.38 Billion | -84.67 Million | -438.01 Million | -41.49 Million | -35.25 Million |
| Earnings Before Tax Margin | -0.10 | 5.48 | -0.12 | -0.38 | -0.13 | -0.17 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 640.5 Million | 642.44 Million | 646.13 Million | 660.52 Million | 2.6 Billion | 660.23 Million |
| Cost of Revenue | 179.74 Million | 284.62 Million | 292.42 Million | 193.42 Million | 760.03 Million | 185.96 Million |
| Gross Profit | 460.76 Million | 357.82 Million | 353.7 Million | 467.1 Million | 1.84 Billion | 474.27 Million |
| Operating Expenses | 505.16 Million | 407.01 Million | 430.77 Million | 238.03 Million | 2.05 Billion | 386.15 Million |
| Selling, General and Administrative Expenses | 291.7 Million | 330.26 Million | 349.39 Million | 148.09 Million | - | 301.86 Million |
| Research and Development Expenses | 72.38 Million | 76.75 Million | 81.38 Million | 89.93 Million | - | 84.28 Million |
| Other Expenses | 141.07 Million | -563 Thousand | -370 Thousand | -143.45 Million | 4.44 Million | -1.79 Million |
| Cost and Expenses | 684.9 Million | 691.63 Million | 723.2 Million | 431.45 Million | 2.81 Billion | 572.11 Million |
| Operating Income | -44.4 Million | -49.19 Million | -77.07 Million | -87.13 Million | -248.55 Million | -64.72 Million |
| Interest Expense | 5.66 Million | 5.64 Million | 5.64 Million | 14.44 Million | 22.28 Million | 5.64 Million |
| Income Tax Expense | 780 Thousand | 3.88 Million | 2.69 Million | 3.51 Million | 760 Thousand | -2.48 Million |
| Earnings before Tax | -32.49 Million | -833.78 Million | -79.19 Million | -25.37 Million | -219.6 Million | -59.55 Million |
| Net Income | -33.27 Million | -837.67 Million | -81.88 Million | -28.89 Million | -220.36 Million | -57.07 Million |
| Earnings Per Share Basic | -0.20 | -4.92 | -0.49 | -0.17 | - | -0.35 |
| Earnings Per Share Diluted | -0.20 | -4.92 | -0.49 | -0.17 | - | -0.35 |
| Weighted Average Shares Outstanding | 170.22 Million | 170.22 Million | 167.73 Million | 166.05 Million | 164.57 Million | 165.11 Million |
| Weighted Average Shares Outstanding (Diluted) | 170.22 Million | 170.22 Million | 167.73 Million | 166.05 Million | 164.57 Million | 165.11 Million |
| Gross Margin | 0.72 | 0.56 | 0.55 | 0.71 | 0.71 | 0.72 |
| EBIT Margin | -0.07 | 0.08 | 0.04 | -0.39 | - | 0.06 |
| Profit Margin | -0.05 | -1.30 | -0.13 | -0.04 | -0.08 | -0.09 |
| EBITDA | -44.4 Million | 49.66 Million | 23.42 Million | -257.57 Million | - | 40.39 Million |
| Earnings Before Tax Margin | -0.07 | -0.08 | -0.12 | -0.13 | -0.10 | -0.10 |
ASAGF
7738
VMRI
300221
5259
000596